Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Intangibles (2022 - 2025)

Sunshine Biopharma (SBFM) has disclosed Change in Intangibles for 4 consecutive years, with $26103.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Intangibles fell 71.79% year-over-year to $26103.0, compared with a TTM value of $615987.0 through Sep 2025, down 39.2%, and an annual FY2024 reading of $322258.0, down 54.34% over the prior year.
  • Change in Intangibles was $26103.0 for Q3 2025 at Sunshine Biopharma, down from $390187.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $686044.0 in Q4 2023 and bottomed at -$402296.0 in Q2 2024.
  • Average Change in Intangibles over 4 years is $146661.5, with a median of $101767.0 recorded in 2022.
  • Peak annual rise in Change in Intangibles hit 4185.27% in 2024, while the deepest fall reached 150.26% in 2024.
  • Year by year, Change in Intangibles stood at $111015.0 in 2022, then soared by 517.97% to $686044.0 in 2023, then crashed by 100.7% to -$4830.0 in 2024, then surged by 640.43% to $26103.0 in 2025.
  • Business Quant data shows Change in Intangibles for SBFM at $26103.0 in Q3 2025, $390187.0 in Q2 2025, and $204527.0 in Q1 2025.